BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37817462)

  • 1. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R
    Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma.
    Lin H; Zhao Z; Hao Y; He J; He J
    Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.
    Song J; Wu X; Liu F; Li M; Sun Y; Wang Y; Wang C; Zhu K; Jia X; Wang B; Ma X
    Biochem Biophys Res Commun; 2017 Aug; 490(2):217-224. PubMed ID: 28602700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
    Wang Y; Zhang R; Cheng G; Xu R; Han X
    Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
    Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
    Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma.
    Dai H; Yi G; Jiang D; Min Y; Li Z
    J Orthop Surg Res; 2024 Jan; 19(1):67. PubMed ID: 38218855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
    Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
    BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
    Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
    Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ZFAS1/miR-1271-5p/HK2 Promotes Glioma Development Through Regulating Proliferation, Migration, Invasion and Apoptosis.
    Zhang B; Chen J; Cui M; Jiang Y
    Neurochem Res; 2020 Dec; 45(12):2828-2839. PubMed ID: 32964288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
    Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
    Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis.
    Wei G; Zhang T; Li Z; Yu N; Xue X; Zhou D; Chen Y; Zhang L; Yao X; Ji G
    Aging (Albany NY); 2020 Apr; 12(7):6172-6190. PubMed ID: 32269179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; He P; Zeng M
    Exp Mol Med; 2023 Apr; 55(4):831-843. PubMed ID: 37009803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
    Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.
    Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ
    Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
    Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
    Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.